Keyword: Antibody-Drug Conjugates (ADC)
News
12.06.2017
- UK biotech Glythera has launched a project to develop next-generation antibody drug conjugates (ADCs) for difficult-to-treat tumors, backed by funding of £1 million from government...
Research & Innovation
06.12.2016
- Despite tremendous challenges facing the pharmaceutical industry, it continues with its commitment to innovation and the discovery of novel drugs to address unmet medical needs...
News
13.10.2016
- CMC Biologics and IDT Biologika announced the addition of Cerbios and Oncotec Pharma to PROVEO, their strategic collaboration for providing a complete and efficient solution to the...
Plant Construction & Process Technology
12.09.2016
-
Growth in the global oncology drug market is an important measure of opportunities in drug development and manufacturing, including for contract manufacturers of active...
Strategy & Management
08.09.2016
- Despite tremendous challenges facing the pharmaceutical industry, it continues with its commitment to innovation and the discovery of novel drugs to address unmet medical needs...
Markets & Companies
02.09.2016
- During the last two decades the pharmaceutical industry was forced to undertake significant structural changes to address mounting challenges from strict regulatory policies, lower...
News
20.11.2015
- Piramal Healthcare UK Ltd., a subsidiary of the Indian Piramal group, is spending £2 million to expand its manufacturing base for antibody drug conjugates at Grangemouth, Scotland...
News
24.09.2014
- Switzerland's Merck Serono, the biopharmaceuticals arm of Germany's Merck KGaA, and US biopharmaceuticals producer Sutro Biopharma have agreed a collaboration and license agreement...
